Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FPR2 | P25090 | 2/20 | 0.32 |
| ▸ | PTPN11 | Q06124 | 3/20 | 0.31 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.31 |
| ▸ | FEN1 | P39748 | 1/20 | 0.31 |
| ▸ | THRA | P10827 | 2/20 | 0.31 |
| ▸ | THRB | P10828 | 2/20 | 0.31 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.30 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8935300 | 1.00 | FPR2 (0.32) | FPR2PTPN11ALOX5APFEN1THRA | |
| SCHEMBL8935333 | 1.00 | FPR2 (0.32) | FPR2PTPN11ALOX5APFEN1THRA | |
| SCHEMBL8935312 | 1.00 | FPR2 (0.32) | FPR2PTPN11ALOX5APFEN1THRA | |
| SCHEMBL8935245 | 0.99 | FPR2 (0.33) | FPR2ALOX5APFEN1GABRA1GABRB2 | |
| SCHEMBL8962794 | 0.97 | FPR2 (0.31) | FPR2PTPN11 | |
| SCHEMBL8962624 | 0.97 | FPR2 (0.31) | FPR2PTPN11 | |
| SCHEMBL8962778 | 0.97 | FPR2 (0.31) | FPR2PTPN11 | |
| SCHEMBL8962743 | 0.97 | FPR2 (0.31) | FPR2PTPN11 | |
| SCHEMBL8962607 | 0.96 | FPR2 (0.32) | FPR2ALOX5APFEN1 | |
| SCHEMBL8935246 | 0.96 | SCN9A (0.32) | FPR2ALOX5APFEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8187494-B2 | Four- or five-ring liquid crystal compound having lateral fluorine, liquid crystal composition, and liquid crystal display device | JNC CORPORATION (JP) | 2012-05-29 | — | — | US | disclosed |